2 withdrawn, 1 active not recruiting. 3 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 3 | Withdrawn 2, Active not recruiting 1 |
Follow Peripheral Nervous System Neoplasms: new trials by email Literature Review of Peripheral Nervous System Neoplasms trials Research Report on Peripheral Nervous System Neoplasms
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Pediatric Long-Term Follow-up and Rollover Study dabrafenib, trametinib - Diffuse Astrocytoma, Anaplastic Astrocytoma | Phase 4 | Active not recruiting | Novartis Pharmaceuticals | 163 | 2019-11-04 | 2026-08-27 |
| Gentamicin Treatment Prior to Schwannoma Surgery - No Residual Function Gentamicin - Vestibular Schwannoma | Phase 4 | Withdrawn | Lund University | 2015-04-01 | 2020-09-11 | |
| Gentamicin Treatment Prior to Schwannoma Surgery - Residual Function Gentamicins - Vestibular Schwannoma | Phase 4 | Withdrawn | Lund University | 2015-01-01 | 2020-09-11 |
Neuroma, Acoustic (2) · Astrocytoma (1) · Ganglioglioma (1) · Ganglioneuroma (1) · Glioblastoma (1) · Glioma (1) · Histiocytosis, Langerhans-Cell (1) · Neuroblastoma (1) · Neurocytoma (1) · Neurofibroma, Plexiform (1) · Neurofibromatosis 1 (1) · Oligodendroglioma (1)
Neoplasms (3) · Neoplasms by Histologic Type (3) · Neoplasms by Site (3) · Neoplasms, Germ Cell and Embryonal (3) · Neoplasms, Nerve Tissue (3) · Nerve Sheath Neoplasms (3) · Nervous System Diseases (3) · Nervous System Neoplasms (3) · Neuroectodermal Tumors (3) · Cranial Nerve Diseases (2) · Cranial Nerve Neoplasms (2) · Ear Diseases (2) · Neurilemmoma (2) · Neuroendocrine Tumors (2)
Gentamicins (2) · dabrafenib (1) · trametinib (1)
Lund University (2) · Novartis Pharmaceuticals (1)
Sweden (3) · Argentina (1) · Australia (1) · Belgium (1) · Brazil (1) · Canada (1) · Czechia (1) · Denmark (1) · Finland (1) · France (1) · Germany (1) · Israel (1) · Italy (1) · Japan (1) · Netherlands (1)
PMID 17917842, PMID 19574236, PMID 19645909, PMID 22027076, PMID 18607963
2023 (1)